| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding | |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | Entrez:930 MIM:107265 HGNC:HGNC:1633 Ensembl:ENSG00000177455 AllianceGenome:HGNC:1633 | |
| Description | CD19 molecule | |||||
| GTO ID | GTC0980 |
| Trial ID | ChiCTR2200058038 |
| Disease | B-Cell Lymphoma |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD19 CAR-T cells |
| Generation | 2nd |
| Phase | Early_Phase1 |
| Recruitment status | Not Recruiting |
| Title | A single-center, single-arm, unblinded clinical study for CD19+CXCR5 cells in patients with non-Hodgkin lymphoma |
| Year | 2022 |
| Country | China |
| Company sponsor | Huizhou Municipal Central Hospital |
| Cohort 1 | |||||||
|
|||||||